vs

Side-by-side financial comparison of Franklin BSP Realty Trust, Inc. (FBRT) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

Zai Lab Ltd is the larger business by last-quarter revenue ($127.1M vs $81.1M, roughly 1.6× Franklin BSP Realty Trust, Inc.). On growth, Franklin BSP Realty Trust, Inc. posted the faster year-over-year revenue change (25.8% vs 17.1%). Over the past eight quarters, Franklin BSP Realty Trust, Inc.'s revenue compounded faster (22.6% CAGR vs 20.8%).

Franklin BSP Realty Trust, Inc. is a publicly traded real estate investment trust (REIT) focused on originating, investing in, and managing a diversified portfolio of commercial real estate debt assets, including first mortgage loans, mezzanine financing and other credit-related real estate products. It operates primarily in the U.S. market, targeting consistent risk-adjusted returns and stable income distributions for investors.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

FBRT vs ZLAB — Head-to-Head

Bigger by revenue
ZLAB
ZLAB
1.6× larger
ZLAB
$127.1M
$81.1M
FBRT
Growing faster (revenue YoY)
FBRT
FBRT
+8.6% gap
FBRT
25.8%
17.1%
ZLAB
Faster 2-yr revenue CAGR
FBRT
FBRT
Annualised
FBRT
22.6%
20.8%
ZLAB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FBRT
FBRT
ZLAB
ZLAB
Revenue
$81.1M
$127.1M
Net Profit
$18.4M
Gross Margin
51.0%
Operating Margin
-54.6%
Net Margin
22.7%
Revenue YoY
25.8%
17.1%
Net Profit YoY
-39.1%
EPS (diluted)
$0.13
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FBRT
FBRT
ZLAB
ZLAB
Q4 25
$81.1M
$127.1M
Q3 25
$89.5M
$115.4M
Q2 25
$49.3M
$109.1M
Q1 25
$50.1M
$105.7M
Q4 24
$64.5M
$108.5M
Q3 24
$54.0M
$101.8M
Q2 24
$50.9M
$100.1M
Q1 24
$54.0M
$87.1M
Net Profit
FBRT
FBRT
ZLAB
ZLAB
Q4 25
$18.4M
Q3 25
$17.3M
$-36.0M
Q2 25
$23.2M
$-40.7M
Q1 25
$24.1M
$-48.4M
Q4 24
$30.2M
Q3 24
$31.6M
$-41.7M
Q2 24
$-2.2M
$-80.3M
Q1 24
$35.9M
$-53.5M
Gross Margin
FBRT
FBRT
ZLAB
ZLAB
Q4 25
51.0%
Q3 25
59.5%
Q2 25
60.6%
Q1 25
63.6%
Q4 24
61.5%
Q3 24
64.1%
Q2 24
64.9%
Q1 24
61.4%
Operating Margin
FBRT
FBRT
ZLAB
ZLAB
Q4 25
-54.6%
Q3 25
-42.3%
Q2 25
-50.3%
Q1 25
-53.3%
Q4 24
-62.6%
Q3 24
-66.6%
Q2 24
-76.0%
Q1 24
-80.7%
Net Margin
FBRT
FBRT
ZLAB
ZLAB
Q4 25
22.7%
Q3 25
19.3%
-31.2%
Q2 25
47.1%
-37.3%
Q1 25
48.0%
-45.8%
Q4 24
46.8%
Q3 24
58.5%
-40.9%
Q2 24
-4.3%
-80.2%
Q1 24
66.6%
-61.4%
EPS (diluted)
FBRT
FBRT
ZLAB
ZLAB
Q4 25
$0.13
$-0.05
Q3 25
$0.12
$-0.03
Q2 25
$0.19
$-0.04
Q1 25
$0.20
$-0.04
Q4 24
$0.28
$-0.09
Q3 24
$0.30
$-0.04
Q2 24
$-0.11
$-0.08
Q1 24
$0.35
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FBRT
FBRT
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$167.3M
$689.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.4B
$715.5M
Total Assets
$6.1B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FBRT
FBRT
ZLAB
ZLAB
Q4 25
$167.3M
$689.6M
Q3 25
$116.7M
$717.2M
Q2 25
$414.1M
$732.2M
Q1 25
$215.4M
$757.3M
Q4 24
$184.4M
$779.7M
Q3 24
$346.2M
$616.1M
Q2 24
$94.8M
$630.0M
Q1 24
$240.0M
$650.8M
Stockholders' Equity
FBRT
FBRT
ZLAB
ZLAB
Q4 25
$1.4B
$715.5M
Q3 25
$1.5B
$759.9M
Q2 25
$1.5B
$791.7M
Q1 25
$1.5B
$810.8M
Q4 24
$1.5B
$840.9M
Q3 24
$1.5B
$667.7M
Q2 24
$1.5B
$704.2M
Q1 24
$1.6B
$762.2M
Total Assets
FBRT
FBRT
ZLAB
ZLAB
Q4 25
$6.1B
$1.2B
Q3 25
$6.2B
$1.2B
Q2 25
$5.6B
$1.2B
Q1 25
$5.7B
$1.2B
Q4 24
$6.0B
$1.2B
Q3 24
$6.3B
$985.3M
Q2 24
$6.3B
$987.4M
Q1 24
$6.0B
$988.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FBRT
FBRT
ZLAB
ZLAB
Operating Cash FlowLast quarter
$291.9M
$-26.0M
Free Cash FlowOCF − Capex
$-26.7M
FCF MarginFCF / Revenue
-21.0%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
15.88×
TTM Free Cash FlowTrailing 4 quarters
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FBRT
FBRT
ZLAB
ZLAB
Q4 25
$291.9M
$-26.0M
Q3 25
$-148.1M
$-32.0M
Q2 25
$11.8M
$-31.0M
Q1 25
$116.2M
$-61.7M
Q4 24
$57.2M
$-55.8M
Q3 24
$97.4M
$-26.8M
Q2 24
$1.9M
$-42.2M
Q1 24
$13.0M
$-90.1M
Free Cash Flow
FBRT
FBRT
ZLAB
ZLAB
Q4 25
$-26.7M
Q3 25
$-35.0M
Q2 25
$-33.9M
Q1 25
$-63.2M
Q4 24
$-58.4M
Q3 24
$-28.2M
Q2 24
$-42.9M
Q1 24
$-91.1M
FCF Margin
FBRT
FBRT
ZLAB
ZLAB
Q4 25
-21.0%
Q3 25
-30.4%
Q2 25
-31.1%
Q1 25
-59.9%
Q4 24
-53.8%
Q3 24
-27.7%
Q2 24
-42.9%
Q1 24
-104.5%
Capex Intensity
FBRT
FBRT
ZLAB
ZLAB
Q4 25
0.5%
Q3 25
2.6%
Q2 25
2.6%
Q1 25
1.5%
Q4 24
2.4%
Q3 24
1.3%
Q2 24
0.7%
Q1 24
1.1%
Cash Conversion
FBRT
FBRT
ZLAB
ZLAB
Q4 25
15.88×
Q3 25
-8.56×
Q2 25
0.51×
Q1 25
4.83×
Q4 24
1.90×
Q3 24
3.08×
Q2 24
Q1 24
0.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FBRT
FBRT

New Point Holdings JVLLC$77.3M95%
Other$2.1M3%
Office Building$1.7M2%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons